Laboratory exposures to brucellae and implications for bioterrorism.
about
Retrospective and prospective perspectives on zoonotic brucellosis.Chemoprophylaxis of Tropical Infectious Diseases.Effect of carbon dioxide on broth microdilution susceptibility testing of Brucella spp.Changing epidemiology of human brucellosis, Germany, 1962-2005.Reliable identification at the species level of Brucella isolates with MALDI-TOF-MSDevelopment and validation of a novel diagnostic test for human brucellosis using a glyco-engineered antigen coupled to magnetic beadsImplications of laboratory diagnosis on brucellosis therapy.An in vivo high-throughput screening approach targeting the type IV secretion system component VirB8 identified inhibitors of Brucella abortus 2308 proliferation.Comparison between antibiotic therapy of Brucellosis with and without vitamin A.Interlaboratory comparison of intact-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry results for identification and differentiation of Brucella spp.Hospital-associated transmission of Brucella melitensis outside the laboratory.Ex vivo innate immune cytokine signature of enhanced risk of relapsing brucellosisBiological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health BiotechnologyCases of human brucellosis in Sweden linked to Middle East and Africa.Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.CCL20 and Beta-Defensin 2 Production by Human Lung Epithelial Cells and Macrophages in Response to Brucella abortus Infection.Knowledge, attitudes and practices (KAP) relating to brucellosis in smallholder dairy farmers in two provinces in Pakistan.A foodborne outbreak of brucellosis at a police station cafeteria, Lima, Peru.Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.Brucellosis of the lung: case report and review of the literature.Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.Efficient production of pronuclear embryos in breeding and nonbreeding season for generating transgenic sheep overexpressing TLR4A literature review of laboratory-acquired brucellosis.Brucellosis in a refugee who migrated from Syria to Germany and lessons learnt, 2016.Aerosol-induced brucellosis increases TLR-2 expression and increased complexity in the microanatomy of astroglia in rhesus macaquesKey role of Toll-like receptor 2 in the inflammatory response and major histocompatibility complex class ii downregulation in Brucella abortus-infected alveolar macrophages.Maternal and congenital brucellosis in Texas: changing travel patterns and laboratory implications.Systematic review of brucellosis in the Middle East: disease frequency in ruminants and humans and risk factors for human infection.Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.Raman spectroscopy as a potential tool for detection of Brucella spp. in milkPrevalence of Brucella antibodies on a previously acute brucellosis infected population: sensitivity, specificity and predictive values of Rose Bengal and Wright standard tube agglutination tests.Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge.Btp Proteins from Brucella abortus Modulate the Lung Innate Immune Response to Infection by the Respiratory Route.Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods.Detection and discrimination of two Brucella species by multiplex real-time PCR and high-resolution melt analysis curve from human blood and comparison of results using RFLP.Outbreak of laboratory-acquired Brucella abortus in Brazil: a case report.Mistaken identity of Brucella infection.Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs.Diagnostic characterization of a feral swine herd enzootically infected with Brucella.Animal and human dose-response models for Brucella species.
P2860
Q33633918-44B0B34B-26AB-4BE2-90FC-09F4EFB4EACBQ33664324-12A50FBE-6A0B-4D68-BC40-2FAEF5FA435FQ33704679-828CBF58-E148-432B-A598-7A34719BEE93Q33877823-B1B9B5AF-332E-4F5B-B55A-23F99C1F4902Q34109202-4EA5A109-7F34-452A-918E-81435224C9AFQ34607842-3FB199A3-E5FE-4966-9BFD-09A3D087231DQ34631365-036A4123-DB83-4020-8294-CCAD0C7F5B48Q34739706-B90658BA-D874-4D9A-AE55-FAF073E07B71Q34813615-B991F539-8B42-498E-B6E3-9DDED1E73D50Q34817122-0ABC98D8-CE56-40CB-98CB-C7C75E3C73DFQ34844010-E8B98D87-DCF3-46EA-B63B-63CFF6F89189Q34990707-E9064503-5D74-4287-BB8E-79A66011AC64Q35545777-1D336B27-905D-4B57-9A97-DA9125C47448Q36020264-BB28611E-03DD-4A31-9468-8FCAD7435A3AQ36097216-092979ED-7C59-4C4A-A482-A54A48B01582Q36136937-B7AFB7F4-2D38-42D9-BE7A-A1D40A6968DAQ36310501-440ECC46-BC97-4F1D-A015-84C6B141D0D1Q36669149-A1388550-8CA2-4E1E-B8E8-6DFB195F91E6Q36969831-9BE105E1-C2CF-4D27-9487-F086F37A19C1Q36977654-7B82A845-D948-4CC3-8946-B6FFE7726052Q37078471-0D0221C8-CC7C-43D4-8AE9-2BF7401021DAQ37085253-B3341F4B-7FC5-4729-9286-55A0322A92FAQ37125232-8D179859-C2B7-4C19-AF1F-BC19AD77A33EQ37205810-B6D4E32C-8A91-4838-A404-94D6FDC12A2AQ37352486-1782FB7C-6B24-46E7-B803-8A1AD0748BE0Q37546393-087B1F69-AE52-4D95-9FBA-FADAFD66034FQ37608097-AE619EC6-90E5-4591-9921-D1A2D9220493Q38617960-1D692325-F553-4F20-A468-4701DDC29EF3Q40978948-3F0771AD-1756-4C1D-89C6-964AAB6E9B22Q41413962-1A1D887A-D422-49D7-876D-E72B920E785BQ41459428-2120F205-5079-4B10-82ED-AE8806E0DC77Q41761576-56BA3071-24C0-4BD7-9B95-ECC492E3A740Q41870524-F8BDD2B1-6AD6-4361-B977-DF8CBEDFB8B5Q41887033-417EC9FC-4219-43A9-8768-68A34E666EB8Q41977886-5285820D-8E27-405E-A6FC-0FF6787A68E8Q42230761-B1D0D673-2531-4064-8F1F-E31856079884Q42971945-0F6FD51B-E60C-43C3-9714-B21F33BEB263Q43194562-89755506-4E5E-4088-9402-B2F3137C65B7Q43222512-4ABF39D0-AF8D-419C-AC95-1ED07869E472Q46455732-D41B28F7-D033-4BC9-91DB-DF04C7764C46
P2860
Laboratory exposures to brucellae and implications for bioterrorism.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Laboratory exposures to brucellae and implications for bioterrorism.
@ast
Laboratory exposures to brucellae and implications for bioterrorism.
@en
type
label
Laboratory exposures to brucellae and implications for bioterrorism.
@ast
Laboratory exposures to brucellae and implications for bioterrorism.
@en
prefLabel
Laboratory exposures to brucellae and implications for bioterrorism.
@ast
Laboratory exposures to brucellae and implications for bioterrorism.
@en
P2860
P921
P356
P1476
Laboratory exposures to brucellae and implications for bioterrorism.
@en
P2093
Ellen Jo Baron
Pablo Yagupsky
P2860
P304
P356
10.3201/EID1108.041197
P577
2005-08-01T00:00:00Z